PM Show Hr 2 | MAHA Looks Into Promising Psychedelic Treatment for PTSD

The Michael Berry Show explores two major themes in this episode: the political fallout from Utah state senator Nate Bluen's controversial past social media posts mocking the LDS Church and Mormons, and the groundbreaking potential of psychedelic treatments—specifically Ibogaine—for veterans suffering from PTSD. The host critiques Bluen’s inflammatory rhetoric, questioning his accountability and the irony of a far-left Democrat running in a deeply Mormon state. He contrasts this with a hopeful narrative around psychedelic medicine, highlighting a recent executive order signed by President Trump that removes regulatory barriers for clinical trials of Ibogaine, a treatment with promising results in reducing addiction and trauma. The episode features personal stories from veterans like Natasha Bayach and Marcus Luttrell, who credit psychedelic therapy with transformative healing after years of failed conventional treatments. The host argues that the stigma around psychedelics stems from the 1970 Controlled Substances Act, which he claims was politically motivated, not scientifically grounded, and calls for a reevaluation of drug policy to prioritize healing over prohibition.